CLINICAL ROLE -
Study: Global Dementia Seen Tripling by 2050 Unless Countries Address Risk Factors
Analysis examines the impacted of expected trends in exposure to high blood sugar, low education levels, obesity, and smoking.
Read More
Daily OTC Pearl: Royal Jelly Propolis
Royal Jelly is rich in proteins, fatty acids, vitamins, minerals, enzymes, carotenoids, and bioflavonoids.
AHA Releases Scientific Statement Addressing CVD for Individuals with T2D
Although fewer than 1 in 5 adults with type 2 diabetes are meeting targets to reduce heart disease risk, available therapies can help when combined with new approaches that barriers to care.
Daily Medication Pearl: Tralokinumab-ldrm (Adbry)
Tralokinumab-ldrm is a human immunoglobulin G4 monoclonal antibody indicated for the treatment of moderate-to-severe atopic dermatitis.
J&J: Real-World Data Demonstrates Durability of Its COVID-19 Vaccine
A single shot protects for up to 6 months against breakthrough infections, hospitalizations, and intensive care unit admissions, Johnson & Johnson says.
Pharmacy Clinical Pearl of the Day: Goiter
A goiter may be associated with an increase or decrease in thyroid hormones.
FDA Approves Daridorexant for Treatment of Insomnia
Daridorexant (Quviviq, Idorsia Pharmaceuticals) is indicated for adults who experience difficulties with sleep onset and/or sleep maintenance.
Study Suggests COVID-19 Vaccination Associated with Small, Temporary Increase in Menstrual Cycle Length
Out of the 3959 who were a part of the study, 2403 of the individuals were vaccinated and 1556 were unvaccinated.
Study: Keytruda Effectively Treats Aggressive Forms of Endometrial Cancer
About 48% of individuals experienced a complete or partial response when treated with pembrolizumab, and about two-thirds also had a response that lasted more than 3 years.
Pharmacist Medication Insights: Emicizumab (Hemlibra) for Hemophilia A
Emicizumab (Hemlibra, Roche) is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with or without factor VIII inhibitors.
Watch
Depression Screenings Improve Care for Patients With Cancer
Incorporating mental distress screenings during cancer care have been historically difficult, despite the fact that these patients tend to be vulnerable to mental health challenges.
Expert Discusses How DMT Differs From Other Psychedelic Medicines
Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discusses DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.
FDA Approves sNDA for Rexulti for Adolescents With Schizophrenia
The agency previously granted a priority review for the supplemental new drug application and also approved the drug in 2015 to treat adults.
Study: Antibiotics Are Often Prescribed for Sore Throats Without a Diagnostic Test
Despite best practice recommendations, prescriptions for acute pharyngitis are frequently not accompanied by testing, Epic Research data show.
Daily OTC Pearl: CeraVe
CeraVe treats or prevents dry skin, as well as chapped lips, diaper rash, and cold sores, among other conditions.
Daily Medication Pearl: Fluticasone/Salmeterol (Wixela)
Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.
Pharmacy Clinical Pearl of the Day: Giardia Infection
Giardia infection is one of the most common causes of waterborne disease in the United States.
Researchers Discover New Molecule for Blood Sugar Regulation Independent of Insulin
The FGF1 hormone regulates blood glucose by inhibiting fat breakdown, although it works differently than insulin.
Optimizing Point-of-Care Testing for Greater Reliability, Efficacy
Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
Relatlimab, Nivoluma Combination Improves Progression-Free Survival in Metastatic Melanoma
Study results establish LAG-3 inhibition as therapeutically relevant third immune checkpoint pathway
Study: Maternal Deaths Caused by Chronic Hypertension Continue to Rise
Additionally, the study showed a 15-fold increase in maternal mortality rates associated with chronic hypertension over the 40-year study period.
Cardiovascular Risks May Be Worse for Women’s Cognition in Middle Age
New study results show that though men are more likely to have heart conditions, the impact on their memory and thinking skills is lower.
Daily OTC Pearl: Similasan Earache Relief
Similasan Earache Relief drops are recommended for earache discomfort, clogged ears, and trapped water.
Study: Taking Higher Doses of Vitamin D Does Not Affect Cancer, CVD Risk
Results of an analysis from the University of Eastern Finland show that supplementation for 5 years had no effect on total mortality or the incidence of these diseases in older individuals.
NCCN Publishes New Guidance on COVID-19 PrEP and Vaccinations for Those With Cancer
The recommendations include full immunization, including third doses and/or any approved boosters.
Expert: It is Critical That Pharmacists Understand the Gravity of the Impact of Sex, Gender on Medicine
Alyson McGregor, MD, of Brown University explains what pharmacists should understand about the impact of sex and gender on medicine within their practice.
Daily Medication Pearl: Fluticasone Furoate and Vilanterol (Breo Ellipta)
Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.
Pharmacy Focus Episode 38: The Revolutionary Impact of Dupilumab on Skin Conditions
Dupilumab has been a breakthrough treatment for patients with atopic dermatitis, but future studies are needed to continue learning about its strength.
Listen
Pharmacy Clinical Pearl of the Day: Gestational Diabetes
In patients with gestational diabetes, there is a higher risk of developing type 2 diabetes.
Portable Prostate Cancer Test May Help Reach Underserved Men
Proof-of-contest is inexpensive and quantifies specific antigens from a drop of blood within minutes.